Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Intensive Adjuvant Chemotherapy for Resected Colon Cancer at High Risk of Recurrence

NCT00005979 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT00005979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Intensive Adjuvant Chemotherapy for Resected Colon Cancer at High Risk of Recurrence
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
July 22, 1998
Completion date
September 1, 2007
Enrollment
Not reported
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer